WVE: Wall street dosen't know how how to price clinical trial data
The position is $6 calls on WVE expiring July 17th. The stock trades for $6.33. Thesis/DD: 1. **THE CATALYST:** The stock fell 50% over a month ago after data on WVE-007, an obesity medication, that showed "less fat burning" than …